Baselga, J.; Cortés, J.; De Laurentiis, M.; Diéras, V.; Harbeck, N.; Hsu, J.; Jin, H.; Schimmoller, F.; Wilson, T. R.; Im, Y.-H.; Jacot, W.; Krop, I. E. und Verma, S.
(2016):
SANDPIPER: Phase III study of the PI3-kinase inhibitor taselisib (GDC-0032) plus fulvestrant in patients with estrogen receptor-positive, HER2-negative locally advanced or metastatic breast cancer enriched for patients with PIK3CA-mutant tumors.
In: Cancer Research, Vol. 76
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 0008-5472 |
| Language: | English |
| Item ID: | 43601 |
| Date Deposited: | 27. Apr 2018 08:04 |
| Last Modified: | 23. Dec 2020 13:16 |
Actions (login required)
- View Item
